Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26F9F89
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,070
Award facts
- Contract value 100% obligated
- $24,069.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,069.96 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania facility. HUMIRA is a biologic immunosuppressant medication commonly used to treat autoimmune conditions including rheumatoid arthritis, psoriasis, and inflammatory bowel disease, making it a critical pharmaceutical supply for military healthcare systems and federal medical facilities.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and prime contractor for the Defense Logistics Agency's global medical supply chain, AmerisourceBergen supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices to support Defense Health Agency operations and other federal healthcare systems. The contractor's established track record of meeting federal procurement requirements through competitive awards and its role as a primary vendor for pharmaceutical commodities underscore its significance in supporting military medical readiness.
Quick answers
Who was awarded contract SPE2DR26F9F89?
SPE2DR26F9F89 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F9F89 worth?
The government has obligated $24,070 on SPE2DR26F9F89.
Is contract SPE2DR26F9F89 an order under another contract?
Yes. SPE2DR26F9F89 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9F89 competed?
The extent of competition for SPE2DR26F9F89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award